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Purpose: In our previous paper we undertook proteomic analysis of the normal developing chick retina to identify proteins
that were differentially expressed during retinal development. In the present paper we use the same proteomic approach
to analyze the development and onset of degeneration in the retinal dysplasia and degeneration (rdd) chick. The pathology
displayed by the rdd chick resembles that observed in some of the more severe forms of human retinitis pigmentosa.
Methods: Two-dimensional gel electrophoresis (pH 4–7), gel image analysis, and mass spectrometry were used to profile
the developing and degenerating retina of the rdd and wild-type (wt) chick retina.
Results: Several proteins were identified by mass spectrometry that displayed differential expression between normal and
rdd retina between embryonic day 12 (E12) and post-hatch day 1 (P1). Secernin 1 displayed the most significant variation
in expression between rdd and wt retina; this may be due to differential phosphorylation in the rdd retina. Secernin 1 has
dipeptidase activity and has been demonstrated to play a role in exocytosis; it has been shown to be overexpressed in
certain types of cancer and has also been suggested as a potential neurotoxicologically relevant target. Its role in the retina
and in particular its differential expression in the degenerate rdd retina remains unknown and will require further
investigation. Other proteins that were differentially expressed in the rdd retina included valosin-containing protein, β-
synuclein, stathmin 1, nucleoside diphosphate kinase, histidine triad nucleotide-binding protein, and 40S ribosomal protein
S12. These proteins are reported to be involved in several cellular processes, including the ubiquitin proteasome pathway,
neuroprotection,  metastatic  suppression,  transcriptional  and  translational  regulation,  and  regulation  of  microtubule
dynamics.
Conclusions: This proteomic study is the first such investigation of the rdd retina and represents a unique data set that
has revealed several proteins that are differentially expressed during retinal degeneration in the rdd chick. Secernin 1
showed the most significant differences in expression during this degeneration period. Further investigation of the proteins
identified may provide insight into the complex events underlying retinal degeneration in this animal model.
Retinitis pigmentosa (RP) is a major cause of blindness
affecting approximately one in every 4,000 individuals [1].
RP  constitutes  a  group  of  genetically  heterogeneous
hereditary retinal diseases characterized by degeneration of
the rod photoreceptors leading to a loss of peripheral vision.
This event has a subsequent effect on the viability of the
remaining  cone  cell  population,  and  these  cells  may  also
become progressively depleted [2,3].
Even though the apparent genetic causes of many forms
of RP have been elucidated, the underlying mechanisms by
which most of these mutations manifest themselves remain
elusive.  This  therefore  warrants  analysis  of  the  disease
mechanisms at the level of the effector molecules, proteins.
Consequently,  knowledge  of  protein  expression  and
posttranslational modification at the outset of disease will
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enable a better understanding of the causal pathology, and this
knowledge  may  enable  earlier  diagnosis  and  direct  the
development of new therapeutics [4].
Investigation  of  human  retinal  degeneration  is  often
hampered from the slow progression of the disease and the
significant difficulties in obtaining tissues that characterize
the  true  progression  of  the  disease  process.  Given  these
difficulties animal models of human retinal pathologies have
been central to the study of retinogenesis and subsequent
degeneration. Animal models offer the possibility to study
pathology in vivo; this has provided new insights into human
diseases that can be used to direct diagnosis and treatment. In
particular, the chick visual system has long been recognized
as one of the most valuable tools to study neural development
and more recently, retinal pathologies. Several studies have
already  been  undertaken  examining  the  normal  retinal
proteome in the chicken [5–7].
The  completion  of  the  chicken  genome  sequencing
project identified one billion base pairs of DNA (about one-
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7third as many as humans) and 20,000–30,000 genes (similar
to the human genome) [8]. The conservation of gene order
between chicken and human is similar to that between human
and  mouse,  in  spite  of  the  much  greater  evolutionary
separation [9]. It is therefore possible to predict both candidate
disease  loci  and  candidate  genes  by  comparison  with  the
human genome [10]. Chicken models of retinal dystrophy
include: retinal degeneration (rd), a model for one form of
Leber  congenital  amaurosis  [11–14],  blindness  enlarged
globe  [14],  retinopathy  globe  enlarged  [10],  a  delayed
amelanotic strain of chicken [15,16], and retinal dysplasia and
degeneration (rdd) [17,18].
The rdd chicken was first detected in 1979 by Randall
and McLachlan [18]; affected birds exhibited limited vision
at  hatching  and  were  less  active  than  sighted  birds.
Histological  analysis  revealed  abnormalities  in  the  retina
extending  from  the  retinal  pigmented  epithelium  (RPE)
through  to  the  inner  nuclear  layer  (INL).  Photoreceptor
degeneration became obvious around embryonic day 16 (E16)
with subsequent progressive photoreceptor loss; at 5 weeks
post hatch, their numbers were greatly diminished and the INL
was significantly depleted. By sexual maturity at 15 weeks,
most birds were blind, and by 6 months there was no response
to visual stimuli [17,19]. The pathology displayed by the
rdd chick resembles that observed in some of the more severe
forms of human RP. Genetic analysis of the rdd chicken has
revealed a null mutation in the Mpdz/Mupp1 gene (data not
shown). In human, Mpdz/Mupp1 is known to interact with
CRB1, mutations in which cause recessively inherited human
RP  and  Leber  congenital  amaurosis  (LCA)  [20,21].  This
animal model may therefore offer valuable insights into the
pathogenesis of RP, and the potential involvement of MPDZ
mutations in human inherited retinal disease is currently being
investigated.
Normal retinal development is characterized by a wave
of neurogenesis and synaptogenesis initiating in the central
retina, with a lag as it migrates to the peripheral retina. The
specific ages that were chosen for this study permitted us to
examine rdd retina during the early phase of degeneration, a
period that corresponds to the major phases of neurogenesis
and  synaptogenesis  in  the  wt  retina.  Histology,  two-
dimensional  gel  profiling,  image  analysis,  and  mass
spectrometry  (MS)  were  used  to  characterize  the  retinal
architecture  and  to  detect  protein  expression  changes
underlying  retinal  development  and  degeneration  in  rdd
versus wt chick.
METHODS
Whole  eye  and  retinal  tissue  collection:  White  leghorn
chickens  (Gallus  gallus  domesticus;  Roslin  Institute,
Edinburgh, UK), fertilized white leghorn eggs, rdd chickens,
and fertilized rdd eggs (Roslin Institute) were maintained by
standard feeding and husbandry procedures under a Home
Office License. E12 and E13 chicks were killed by chilling in
−80  °C  for  15  min;  E17  and  E19  chicks  were  killed  by
decapitation; and post-hatch day 1 (P1) chicks were killed by
cervical dislocation. The eyes were dissected and retinas for
proteomic analysis were carefully peeled free of RPE. Retinas
were washed in chilled PBS (137 mM NaCl, 2.7 mM KCl,
4.3 mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4) to remove any
extraneous RPE, snap frozen in liquid nitrogen within 10 min
of  death,  and  subsequently  stored  at  −80  °C.  All  animal
procedures  were  performed  in  compliance  with  the  UK
Animals (Scientific Procedures) Act 1986.
Histology:  Resected  eyes  were  perforated  and  immersion
fixed in buffered 4% (w/v) paraformaldehyde (4 h, 4 °C;
Sigma-Aldrich, Poole, UK), dehydrated sequentially in 70%
(v/v; 2×30 min), 95% (v/v; 2x30 min), 100% (2×30 min)
industrial grade methylated spirits followed by immersion in
100% ethanol (2×30 min) and 100% xylene (2×30 min to
render the tissue miscible with wax impregnation, embedded,
and  microtome  sectioned  (5  μm).  Retinal  sections  were
stained with hematoxylin and eosin.
Retinal  protein  extraction  and  2  dimensional  gel
electrophoresis (2DE): A total of three wt and rdd chicks were
analyzed at E12, E13, E17, E19, and P1. The retinas from each
chick  were  pooled,  and  retinal  protein  was  collected  and
processed as previously described [5]. The retinal proteins
were analyzed using two-dimensional PAGE (2D PAGE), as
previously described [5]. Briefly, retinal tissues were ground
to a powder in liquid nitrogen, and protein was extracted in
40 mM ammonium bicarbonate buffer to which dithiothreitol
(DTT; Melford Labs, Suffolk, UK) was added (approximately
5:1 [w/v]). The sample was sonicated (15 min, 4 °C), extracted
for 1 h on ice with vortexing, dialyzed (24 h, 4 °C) using Slide-
A-Lyzer® dialysis cassettes (3,500 molecular-weight cutoff;
Pierce, Leicestershire, UK), lyophilized, and reconstituted in
lysis  solution  (7  M  urea,  2  M  thiourea,  2%  3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate
[CHAPS], 20mM DTT, 0.5% immobilized pH gradient [IPG]
buffer, pH 4–7). Protein quantification was performed using
a  PlusOne  2-D  Quant  Kit  (Amersham  Biosciences,
Buckinghamshire, UK). Retinal protein extract (1 mg) was
diluted to generate a final volume of 400 µl with rehydration
buffer (7 M urea, 2 M thiourea, 2% CHAPS, 80 mM DTT,
0.5%  IPG  buffer  containing  3′,  3′’,  5′,  5′’
tetrabromophenolsulfonephthalein  (bromophenol  blue;
Sigma-Aldrich)  and  added  to  18-cm  pH  4–7  IPG  strips
(Amersham Biosciences). Following rehydration (18 h, room
temp),  isoelectric  focusing  (IEF)  was  performed  using  a
Multiphor II system (20 °C) with a MultiTemp III circulator
and an EPS 3501 XL power supply (200 V for 1 V hour [Vh],
3,500 V for 3,000 Vh, and held at 35,000 V for 52,000 Vh;
Amersham Biosciences).
IPG  strips  were  equilibrated  for  15  min  in  10  ml
equilibration buffer (50 mM Tris-Cl, pH 8.8, 6 M urea, 30%
[v/v]  glycerol,  2%  [w/v]  sodium  dodecyl  sulfate  [SDS],
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8bromophenol blue) containing 100 mg DTT. Following this,
the IPG strips were added to 10 ml of fresh equilibration buffer
containing  250  mg  iodoacetamide  (Sigma-Aldrich)  for  a
further  15  min.  SDS–PAGE  was  performed  using  an
EttanTM DALTsix vertical system (Amersham Biosciences)
with  a  MultiTemp™  III  thermostatic  circulator  (25  °C;
Amersham Biosciences). Proteins were resolved by 2D PAGE
under 600 V, 400 mA for 30 min; followed by 600 V, 400 mA,
17  W/gel  for  4  h.  Gels  were  then  fixed,  stained  with
Coomassie brilliant blue G-colloidal (Sigma-Aldrich), and
destained using standard procedures. Gels were stored in 25%
(v/v) ammonium sulfate (BDH Laboratories, Leicestershire,
UK) solution at 4 °C.
Image analysis: Gels were scanned as 16-bit grayscale tiff
image files with a GS-800 calibrated densitometer (Bio-Rad
Laboratories  Inc.,  Hercules,  CA),  and  the  protein  spot
intensities were quantified using Progenesis PG220 version
2006 build 2417.2 (Nonlinear Dynamics Ltd., Newcastle upon
Tyne,  UK).  Gels  from  wt  (n=3  independent  biologic
replicates)  and  rdd  (n=3  independent  biologic  replicates)
retinas from E12, 13, 17, 19, and P1 were imported into five
separate experiments, spots were detected and matched, and
volumes normalized within triplicate (n=3) gel sets to create
an average gel for each age and phenotype. The following
parameters for protein spot detection were used: minimum
spot radius of 16 (the smallest area perceived as a spot),
minimum spot intensity (volume above base level), and split
factor 7 (a value between 1 and 9 controls automatic splitting
of  spots  that  may  have  merged  together;  as  this  number
increases  splitting  becomes  more  vigorous).  Manual
verification and editing of spot matching were performed, and
only spots matched in at least two-thirds of the gel images
were  considered  for  further  analysis.  Gels  from  each
experiment  were  processed  using  the  normalization  mode
(this erases intensity differences of similar spots in different
gels not due to regulation but to experimental variability of
the method, e.g., protein load or Coomassie stain intensity).
To normalize spot volume, the volume of a spot is divided by
the total volume of the entire image (volume is defined as the
optical density [OPD]) and is calculated using the following
formula: (the OPD of a spot) × (the area occupied by a spot).
Subsequently  spots  were  filtered  to  find  significant
differences within certain detection limits; only those filtered
spots  exceeding  an  intensity  threshold  of  1.5  to  twofold
increase or decrease between wt and rdd were subjected to
further  analysis.  The  threshold  regulation  factor  for  the
significance level was set at p≤0.05; spots regulated more than
the factor required for significance were further considered as
candidate  spots  and  subsequently  subjected  to  manual
verification. The two average gels (one wt and one rdd) from
each of the five separate experiments were imported into one
new  experiment.  Any  significant  differences  in  spot
intensities  that  were  detected  in  the  previous  individual
experiments  were  analyzed  at  all  other  ages  in  the  new
experiment.  A  Student  t-test  and  Analysis  of  Variance
(ANOVA) were used to analyze differences in spot values,
and spots that showed significant variation between wt and
rdd retina were identified by MS.
Trypsin  digestion  and  Matrix-assisted  laser  desorption/
ionization–time of flight (MALDI-TOF) analysis: Calibration
of  the  mass  spectrometer  was  first  performed  using
Angiotensin I - 1296.6853, adrenocorticotropin (ACTH) [1–
17] 2093.087, ACTH [18–33] 2465.199, and ACTH III [7–
33] 3657.929. The calibration standard mix must match at
least three of these peaks at a max outlier of 50 ppm. Following
this  calibration  samples  were  internally  calibrated  using
trypsin autolysis peaks at masses 842.500 and 2211.100, the
maximum outlier error of this calibration is 50 ppm. If these
peaks were not detected, we deferred to the default calibration,
which is routinely updated as above. Proteins analyzed by
MALDI-TOF  (Durham  University,  Durham,  UK)  were
tryptically  digested  using  Genomic  Solutions  ProGest
(Genomic  Solutions®,  Ann  Arbor,  MI),  transferred  to  a
microtiter  plate  (PE  Biosystems  Symbiot  robot;  PE
Biosystems,  Warrington,  UK),  lyophilized  in  a  vacuum
concentrator,  resuspended  in  10  µl  of  0.1%  formic  acid,
sonicated, and spotted onto a MALDI target plate before MS
analysis,  using  a  Voyager  DE-STR  MALDI-TOF  mass
spectrometer (PE Biosystems).
Database searching: Peptide peak lists were generated with
MASCOT Wizard and submitted to Mascot (version 2.1) for
peptide mass fingerprint database searching of the National
Center for Biotechnology Information (NCBI) database. The
Mowse scoring algorithm [22] was used to determine the
significance  of  the  identity;  it  indicates  if  the  identity  is
significant and if it would be expected to occur at random with
a frequency of less than 5%. Additional criteria were used to
ensure  correct  protein  identifications.  These  included
ensuring the matched peptides were the most abundant peaks
in the mass spectrum, the theoretical isoelectric point and
molecular weight of the identified protein correlated with the
spot’s position on the 2D gel, and sequence coverage was
high.
Small-molecular-weight  proteins  are  often  difficult  to
definitively  identify  because  they  generate  only  a  small
number of short peptide fragments after tryptic digestion.
Since  Mascot  does  not  have  an  option  to  search  “Gallus
gallus” as the taxonomy, “Protein Prospector” was used to
match small-molecular-weight proteins. The MS-Fit tool in
Protein Prospector offers the option of refining the search
parameters by entering the pI of the protein based on its
position on the 2D gel and refining the taxonomy to Gallus
gallus.  After  scanning  the  possible  matches  generated  in
Protein  Prospector,  the  matched  peptides  were  cross-
referenced with the raw spectra. When the matched peptides
were the most intense peaks in the spectra, there was a higher
possibility that the match was correct. Settings used in Protein
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9Prospector were: Database Search: NCBInr.2006.02.16; MW
of Protein: All; Protein pI: 4–7; Min No of peptides required
to  match:  4;  Taxonomy:  Gallus  gallus;  Report  MOWSE
scores:  PFactor  0.4;  Instrument:  MALDI  TOF;  Peptide
masses are: monoisotopic; Mass Tolerance: ±50 ppm; Digest:
Trypsin; Max no of missed cleavages: 1; Cys modified by:
acrylamide.
RESULTS
Histology was performed to characterize the progression of
retinal development and subsequent degeneration in the rdd
retina with age-matched wt chick retina. This data aided the
interpretation of 2D profiles and observed protein expression
changes. Histology revealed that the characteristic developing
laminated retinal architecture was comparable at E13 (Figure
1A,B)  in  wt  and  rdd  retina.  By  E18,  however,  the  outer
plexiform  layer  (OPL)  and  outer  nuclear  layer  (ONL)
displayed  a  degree  of  disorganization  in  which  the
characteristic  demarcation  between  these  two  layers  had
started to deform; this in turn led to folding in the ONL and
INL (Figure 1C,D). By P1 the photoreceptor layer displayed
distinct disorganization. At this stage rdd chicks have only
limited vision [17] and the pathological changes in the retinal
architecture were quite pronounced, with buckling of the OPL
and  detachment  of  photoreceptors  from  the  RPE  (Figure
1E,F). Magnified images of the ONL and OPL in the rdd chick
at E13 (Figure 1I), E18 (Figure 1J), and P1 (Figure 1K) clearly
demonstrate the degenerative changes occurring in the outer
layers of the retina with buckling of the OPL and detachment
of the photoreceptors from the RPE. By P21 the rdd retina was
reduced in thickness to about half that of the wt retina, the INL
thickness was greatly diminished, and the OPL, ONL, and
outer segments were no longer distinguishable as these layers
had atrophied and merged in rdd chicks (Figure 1G,H). This
verifies the lack of electroretinogram (ERG) response by 3
weeks post hatch [17].
Proteomic analysis was performed to identify proteins
that were differentially expressed in the wt versus rdd retinas.
An average of 1,531 spots per gel were detected in the pH
range 4–7 (Figure 2A), which was chosen for these analyses
because it provided the best resolution of the major protein
population present in the retinal samples. Using Progenesis
image  analysis,  seven  proteins  were  detected  that
demonstrated significant variation in expression in the rdd
versus wt retina. These proteins were identified by MS (Table
1, Figure 2A) and included valosin-containing protein, β-
synuclein,  stathmin  1,  histidine  triad  nucleotide-binding
protein, nucleoside diphosphate kinase, 40S ribosomal protein
S12, and secernin 1. γ-Actin and β-tubulin were also identified
by MS and used as loading controls for the gels. There was no
significant difference in the levels of actin and tubulin in the
wt and rdd gels from E12 to P1 (Figure 2B). Fold changes in
the  expression  of  the  identified  proteins  were  calculated
(Table  2),  probability  values  were  determined  using  the
Student  t-test,  and  one-way  ANOVA  were  performed  to
compare  the  average  normalized  volumes  of  proteins
identified by MS from wt and rdd retina (Table 3).
The  most  significant  outcome  in  this  study  was  the
differential  expression  of  secernin  1  in  the  rdd  retina.  It
appeared to resolve as four distinct spots (Figure 3A), two of
which were identified by MS; resolution of secernin 1 along
the  acidic–basic  axis  is  indicative  of  a  posttranslational
modification  (PTM).  Scansite  Molecular  Weight  and
Isoelectric Point Calculator analysis of the observed interspot
pI  distances  (0.03  pI  units)  suggested  that  the  observed
interspot  pI  distances  were  compatible  with  differential
phosphorylation states of secernin 1; however, this was not
established definitively and would require further in depth MS
analysis. Secernin 1 spots were present at all ages in the wt
and rdd retina; however, there were significant differences
between  the  expression  of  “isoform  a”  and  “isoform  b”
(Figure 3C right panel and Figure 3C middle panel), with a
13.6 fold increase in the expression of “isoform a” in the
rdd retina at E13 relative to wt expression at the same age. In
fact, the expression of isoform “a” was significantly increased
in the rdd retina up to P1 (Table 2). The total expression of all
four isoforms of secernin 1 (Figure 3C left panel) was summed
and compared using a Student t-test to determine if the total
expression of secernin 1 in wt and rdd retina differed. This
analysis revealed no significant difference in total expression
at each age, thus indicating that the differences were due to
PTM.
DISCUSSION
This is the first semiquantitative proteomic analysis of the
developing and degenerating rdd retina, which presents with
retinal degeneration akin to several severe forms of human
retina  degeneration.  The  mechanisms  underlying  retinal
degeneration in RP remain poorly understood despite several
decades of primarily genetic-driven research; these studies
have  exploited  the  increasing  sophistication  of  genomic
analysis  of  both  human  and  animal  models  of  retinal
degeneration. Nonetheless, given the divergence of mutant
genes identified, the progression of the underlying spectrum
of pathologies is largely characterized by the general process
of photoreceptor death, and yet these processes remain ill
defined. The present study used histology to view the onset
and  progression  of  retinal  degeneration,  and  proteomic
analysis was used to identify proteins that were differentially
expressed in the rdd retina.
Interestingly, four of the differentially expressed proteins
identified  in  the  rdd  retina—valosin-containing  protein,
stathmin  1,  40S  ribosomal  protein  S12,  and  nucleoside
diphosphate  kinase—have  been  shown  to  exhibit  altered
expression following proteomic analysis in animal models of
the  human  neurodegenerative  pathologies,  Alzheimer  and
Parkinson  diseases  [23].  Valosin-containing  protein  is  a
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10member of the ubiquitously expressed multifunctional AAA
+ (ATPase associated with various activities) protein family
and  has  been  implicated  in  a  range  of  cellular  functions,
including  organelle  biogenesis  and  regulation  of  the
ubiquitin–proteasome  system  [24].  Valosin-containing
protein exhibited a lower parallel level of expression in the
developing and early degenerate rdd versus the wt retina.
Given the diversity of cellular roles attributed to valosin-
containing protein, this observation in the rdd versus wt retina
may reflect an overall decrease in cellular function.
Stathmin was detected in our previous report where it was
shown  to  decrease  significantly  during  normal  retinal
development  in  the  chick  [5].  In  general,  the  pattern  of
stathmin expression observed in the developing rdd retina was
more uniform with an overall decrease in expression at P1.
Analysis  of  retinal  regeneration  in  the  newt  Cynops
pyrrhogaster detected increased stathmin expression from an
early phase, and its expression continued until the retinal
architecture  was  restored  [25].  The  observed  stathmin
modulation in the degenerate rdd retina versus the wt retina
would be supportive of the concept that stathmin plays an
important role in the construction and maintenance of retinal
structure and its neural network [25].
Secernin  1  is  a  cystolic  50-kDa  protein  reported  to
regulate exocytosis in permeabilized mast cells [26]; however,
its expression in the normal wt chick retina, bovine and rat
brain, and in 12 normal human tissues with highest expression
in  nervous  tissue  would  suggest  a  more  generic  function
[26]. This view is supported by the ubiquitous expression of
three secernin genes in many different murine [27] and human
cells and is indicative of a widespread function rather than a
specific role in mast cell exocytosis. This preliminary study
Figure 1. Retinal dysplasia and degeneration (rdd) retinal histology. Microtome sections of retina stained with hematoxylin and eosin. Normal
retinal morphology is evident in the developing wt chick at embryonic day (E)13 (A), E18 (C), and post-hatch day (P)1 (E). At E13 the gross
retinal morphology of the rdd retina (B) is similar to that of the wt retina; however, the degenerative changes are obvious in the rdd retina at
E18 (D) and P1 (F). Magnified images of the outer plexiform layer (OPL) and outer nuclear layer (ONL) show the progressive disorganization
of the outer retinal layers of the rdd chick from E13 (I), E18 (J), and P1 (K).
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11has  shown  there  is  significant  differential  expression  of
secernin 1 in the rdd retina. Although there was no significant
change  in  the  total  expression  of  secernin  1,  there  were
significant  differences  in  the  expression  of  the  different
isoforms,  namely  isoform  “a,”  which  was  significantly
upregulated at all ages in the rdd chick. Scansite Molecular
Figure 2. Protein profiles from wild type (wt) and retina dysplasia and degeneration (rdd) retina. A-D: Representative 2D protein profiles from
embryonic day (E)12, E13, E17, E19, and post hatch day (P)1 rdd and wt chick retina displaying positions of proteins that were identified by
MS (Table 1). The positions of two housekeeping proteins (β-tubulin and actin) are also shown. Proteins were extracted using 40 mM
ammonium bicarbonate; 1 mg of retinal protein was separated in the first dimension on an 18-cm pH 4–7 IPG strip and in the second dimension
on a 12% polyacrylamide gel. The protein spots were visualized with Coomassie brilliant blue G-colloidal. B: Levels of actin and tubulin in
the rdd and wt retina. γ-Actin and β-tubulin were identified by MS and used as loading controls for the gels. There was no significant difference
in the levels of actin or tubulin in the wt and rdd gels from E12 to P1 (B). Bar charts show age plotted against arbitrary units, with SEM.
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12Weight  and  Isoelectric  Point  Calculator  analysis,  which
calculates the isoelectric point of a protein given different
phosphorylation  sites,  predicted  that  these  isoforms  may
represent  phosphorylation  events;  however,  this  remains
unsubstantiated  and  will  require  further  analysis.
Additionally,  the  different  isoforms  could  be  due  to  the
expression of two or more secernin genes; two secernin genes
have  been  identified  in  the  chicken  genome,  secernin1
(located  on  chromosome  2)  and  secernin  2  (located  on
chromosome 7). The human genome contains three secernin
genes, and there are at least two splice variants of secernin 2.
Therefore different genes and splice variants may account for
the four secernin 1 proteins identified in chick retina.
Given the widespread expression of secernin 1 in many
tissues, secernin 1 is likely to have other functions beyond the
regulation  of  mast  cell  exocytosis.  Indeed,  secernin  1
expression was upregulated in gastric cancer and colon cancer
where it was implicated in cell growth [28], and it was found
to be one of several novel genes overexpressed in Barrett's
esophagus  high-grade  dysplasia  [29].  Several  proteomic
studies have identified secernin 1 as being upregulated in the
dorsolateral prefrontal cortex of patients with schizophrenia
[30], and consistent with a decline in neuronal function, it was
downregulated in the cerebral cortex of sleep-deprived mice
[31].  Other  studies  suggest  that  secernin  1  is  a
neurotoxicologically relevant target as proteomic analysis of
rat striatal synaptosomes identified secernin 1 as one protein
that  was  progressively  and  significantly  adducted  during
acrylamide  intoxication  [32].  At  present,  however,  it  is
difficult to suggest a reasoned function for secernin within the
retina and for its variant expression in the rdd retina, and as
such,  it  is  not  possible  to  attribute  any  linkage  between
secernin 1 and Mupp1. Nevertheless, the data presented in this
study clearly show a real alteration in secernin 1 expression
in  the  degenerating  retina  that  warrants  further  study.
Preliminary  analysis  using  the  only  secernin  1  antisera
currently  available  detected  numerous  anomalous  bands
following western blot analysis, and while it did detect a cell
population in the retina, these observations cannot be relied
upon  because  of  potential  cross-reaction  of  antisera  with
unknown antigens expressed in retinal tissue.
The pathology displayed by the rdd chick resembles that
observed in some of the more severe forms of human RP. It
is now known that the rdd chicken carries a null mutation in
the Mpdz/Mupp1 gene (Ali et al., manuscript in preparation).
At present there are no reports in the literature of a direct
association between mutations in Mpdz/Mupp1 and rdd in
humans;  there  is,  however,  evidence  to  show  that  Mpdz/
Mupp1is directly associated with Crumbs homolog 1 (Crb1).
Crb1  is  localized  to  the  subapical  region  adjacent  to  the
adherens junction complex at the outer limiting membrane in
the retina, and loss of Crb1 function leads to either recessively
inherited RP or LCA in humans [33]. This animal model may
therefore offer valuable insights into the pathogenesis of RP,
and the potential involvement of Mpdz/Mupp1 mutations in
human  inherited  retinal  disease  is  currently  being
investigated. The current proteomic analysis did not detect
Mupp1,  which  has  a  molecular  weight  of  approximately
220 kDa, not surprising given it is a large protein beyond the
molecular-weight range arrayed in this study.
In summary, this investigation has successfully identified
and provided novel data on several proteins differentially
expressed  during  retinogenesis  and  with  the  onset  of
degeneration in the rdd chick. These proteins are involved in
signaling,  nucleoside  biosynthesis,  regulation  of
transcription, and protein synthesis. This study has generated
novel data as some of these proteins have not previously been
implicated in retinal degeneration. In particular this is the first
report to demonstrate modulation of secernin 1 in relation to
a retinal pathology. Consequently, the rdd chick would appear
TABLE 1. GALLUS GALLUS PROTEINS IDENTIFIED BY MASS SPECTROMETRY
Spot
number Protein Accession #
Mowse
score
%
Sequence
coverage Mr (Da)
Calculated
pI
Number
peptides
matched
1 Valosin containing protein (VCP) gi|113206112** 348 66 89953 5.14 18
2 Synuclein, beta (β-synuclein) 574 44.4 14063 4.4 5
3 Stathmin 1/ oncoprotein 18 gi|50053682
**
97 47 17072 6.18 12
4 PREDICTED: Similar to Histidine triad
nucleotide binding protein (Hint-1)
1450 58.7 13759 6.3 9
5 PREDICTED: Similar to Nucleoside
diphosphate kinase (NDK1)
355 86.9 17337 5.6 11
6 PREDICTED: Similar to 40S ribosomal
protein S12
gi|50742739** 81 75 14935 6.81 8
7 PREDICTED: Similar to KIAA0193/
Secernin 1 (SCRN1)
gi|118086002** 106 43 46638 4.69 18
Proteins identified by mass spectrometry that displayed significant differences in expression in the wild type (wt) and retinal
dysplasia and degeneration (rdd) retina.
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 Figure 3. Differential expression of secernin 1 in the retinal dysplasia and degeneration (rdd) retina. A: Representative 2D montage images
generated using Progenesis 2D image analysis software, revealing the modulated expression of secernin 1 in the wt and rdd chick. Two
isoforms of secernin 1 (isoforms “a” and “b”) were identified by MS (arrows). The expression of isoform “a” is significantly increased from
E13 onwards in the rdd retina, while it is only present at very low levels in the wt retina. B: 3D images of the 2D gels generated using Progenesis
of the two isoforms of secernin 1 identified by MS. The increased expression of isoform “a” is evident from E13 onwards in the rdd retina.
C: Graphical representation of expression of secernin 1 in the wt and rdd chick displaying the expression of isoform “a” (right panel), isoform
“b” (middle panel), and total expression of secernin 1 (left panel). Age is plotted against average normalized volume (n=3±SEM).
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